CASC9 and glioblastoma: Overall survival (OS) curve calculated by the Kaplan−Meier method and survival for GBM patients showed that the patients who had high levels of CASC9 within tissues had remarkably shorter overall survival rate as compared to low levels of CASC9 (Fig. 2D).